Boothwyn Pharmacy LLC Recalls
4 recalls from federal safety databases (FDA, CPSC). Sourced directly from government enforcement feeds.
Drug Recalls (4)
- Class II
July 9, 2025
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Subpotent Drug
- Class III
July 9, 2025
Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496
Subpotent Drug
- Class II
July 9, 2025
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Subpotent Drug
- Class II
July 9, 2025
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Subpotent Drug
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.